ARRIS International plc (NASDAQ:ARRS) [Trend Analysis] retains strong position in active trade, as shares scoring 0.67% to $26.99 in a active trade session, while looking at the shares volume, around 1.3 Million shares have changed hands in this session. ARRIS International plc (ARRS) revealed that its Board of Directors has appointed Bruce McClelland as Chief Executive Officer effective September 1, 2016. McClelland also was appointed to serve on the Board of Directors effective the same date.
Bob Stanzione will become ARRIS Executive Chairman in addition to continuing to serve as Chairman of the Board of the Company. “Since its formation, ARRIS has grown from a small joint venture to a global leader in entertainment and communications technology,” said Bob Stanzione. “With integration efforts from the Pace acquisition substantially complete, now is the right time to transition the role of CEO to a new leader who will continue ARRIS’s growth and success. Bruce has played an integral role in transforming the Company since he joined the ARRIS Interactive Joint Venture more than 16 years ago. He will provide leadership and strategic vision to keep ARRIS and our customers ahead of rapid pace of change and will ensure we remain at the forefront of tomorrow’s connected world.” The firm has institutional ownership of 87.40%, while insider ownership included 0.30%. ARRS attains analyst recommendation of 1.90 with week’s performance of -2.84%. Investors looking further ahead will note that the Price to next year’s EPS is 13.42%.
Shares of Imprivata, Inc. (NYSE:IMPR) [Trend Analysis] swings enthusiastically in regular trading session, it an increase of 0.05% to close at $19.15. Imprivata (IMPR) announced that University of Utah Health Care will implement Imprivata PatientSecure, the positive patient identification platform for healthcare, to eliminate duplicate medical records and improve patient safety. As part of the deployment, the University of Utah Health Care system will install the Imprivata positive patient identification platform across their enterprise, including 4 university hospitals and 11 community clinics that facilitate nearly 1.6 million patient visits per year. Moving forward to saw long-term intention, IMPR; experts calculate Return on Investment of -45.50%. The stock is going forward its fifty-two week low with 112.78% and lagging behind from its 52-week high price with -10.72%. IMPR last month stock price volatility remained 0.24%.
Sprouts Farmers Market, Inc. (NASDAQ:SFM) [Trend Analysis] knocking active thrust in leading trading session, shares an increase of 0.87% to 23.17 with around 2.14 Million shares have changed hands in this session. The stock is going forward its fifty-two week low with 41.19% and lagging behind from its 52-week high price with -22.77%.
On the other side, the positive performance for the quarter recorded as -4.73% and for the year was 18.27%, while the YTD performance remained at -12.86%. SFM has Average True Range for 14 days of 0.65.